Polaris Venture Management Co. V as of Dec. 31, 2015
Portfolio Holdings for Polaris Venture Management Co. V
Polaris Venture Management Co. V holds 9 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Trevena | 22.0 | $28M | 2.7M | 10.50 | |
| T2 Biosystems | 17.4 | $22M | 2.0M | 10.94 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 14.1 | $18M | 1.8M | 9.83 | |
| Pulmatrix | 11.9 | $15M | 3.6M | 4.20 | |
| Ocular Therapeutix (OCUL) | 9.1 | $12M | 1.2M | 9.37 | |
| Genocea Biosciences | 8.2 | $10M | 2.0M | 5.27 | |
| Cerulean Pharma | 7.2 | $9.2M | 3.3M | 2.80 | |
| Fate Therapeutics (FATE) | 6.5 | $8.3M | 2.5M | 3.37 | |
| Bind Therapeutics | 3.6 | $4.6M | 2.0M | 2.29 |
